Healing After Trauma: Cutting-Edge Hormonal and Complimentary Approaches for Restoring Balance & Wellness
Physical, Sexual, and Emotional Trauma and the Physiological Changes that Follow
#trauma #aces #ptsd #neuroscience #neuroendocrine #neuroimmune#publichealth #survivors #mentalhealth #psychiatry #wellness #gutbrainaxis#nutrition #sleephealth #diet #hydration #support
Explore innovative hormonal therapies and holistic strategies for overcoming trauma-related symptoms, restoring balance, and promoting mental wellness.
Trauma, whether physical, sexual, or emotional, can lead to a cascade of physiological changes in the body and brain. These changes may persist long after the initial traumatic event, impacting an individual's overall well-being and potentially resulting in long-lasting mental and physical health issues. Understanding these physiological changes is crucial for effective intervention and treatment. I'll attempt to provide an overview of some of the various physiological alterations that follow trauma.
Historical Perspectives on Trauma
Trauma accounts can be traced back to ancient Greek and Persian military history writings. For instance, descriptions of psychological trauma experienced by soldiers and the physiological changes they experienced can be found in accounts of Alexander the Great's campaigns (Engels, 1978). These historical documents shed light on recognizing trauma's effects on individuals, even in ancient times. Since then, our understanding of trauma and its physiological consequences has evolved significantly, allowing for more targeted and effective interventions.
Physical Impact of Trauma: Brain Architecture & Brain Waves
Trauma affects the brain's architecture by causing shrinkage in key areas, including the prefrontal cortex, corpus callosum, and hippocampus (van der Kolk, 2014). The amygdala, responsible for processing fear and emotional reactions, becomes enlarged and more reactive (Teicher et al., 2002). Restoring safe and stable nurturing relationships can help reverse these detrimental changes (Cozolino, 2014).
Trauma can also disrupt brain wave patterns, leading to anxiety, inability to concentrate, and seizures. Neurofeedback, meditation, and mindful action can help restore normal brain wave patterns and improve emotional regulation (Marzbani et al., 2016).
Neural Pathways & Neurotransmitters
Trauma can impact neural pathways, consciously and unconsciously, changing thought patterns and habits of mind. Interventions such as neurofeedback, meditation, and positive self-talk can help rewire these pathways and promote healing (Siegel, 2010).
Traumatic experiences can alter neurotransmitter balance, making individuals more vulnerable to addiction due to dopamine deficits and causing depression due to low serotonin levels (Nemeroff, 2004). Targeted therapies and medications can address these imbalances and alleviate symptoms.
Hormonal Changes
Following trauma, prolonged high cortisol and ghrelin levels can increase stress reactivity and impact other hormone glands, such as the thyroid (Heim et al., 2000). Oxytocin and other hormones can help mitigate these negative effects and promote healing (Carter, 2014).
Toxin Elimination & Cellular Changes
Trauma can impair the body's ability to eliminate toxins, leading to gut imbalances and other issues. Dietary and lifestyle changes can help restore balance and support overall health (Cryan & Dinan, 2012). Cellular changes, such as shortened telomeres, can result from trauma, increasing the risk of premature aging and cancer (Epel et al., 2004). Social support and stress management can help counteract these changes (Uchino, 2006).
Epigenetics & the Nervous System
Epigenetic changes in response to trauma can turn genes on or off, affecting the individual and future generations (Yehuda & Bierer, 2009). Creating safer environments and interventions can help reverse these effects. Trauma can also lead to nervous system dysregulation, with an overactive sympathetic nervous system and an underactive parasympathetic nervous system (Porges, 2007). Stress reduction techniques and therapies can help restore balance and improve overall well-being.
Immune System Changes
Trauma can alter immune system function, resulting in unchecked inflammation and increased risk for inflammatory diseases such as asthma and arthritis (Miller et al., 2009). Meditation, mindful action, walking in nature, diet, and rest can all help reduce inflammation and support immune system function (Irwin & Olmstead, 2012).
Treatment of Trauma-Related Symptoms: Hormonal, Neurotransmitter, & Immunological Interventions
The physiological changes caused by trauma are complex and multifaceted, often involving hormonal imbalances, neurotransmitter alterations, and immune system dysregulation. Therefore, effective treatment strategies must address these various aspects to promote healing and recovery. In this section, we will discuss several hormonal and immunological interventions that can potentially improve the symptoms and physiological consequences of trauma.
Oxytocin
Oxytocin, commonly known as the "love hormone," is crucial in social bonding, trust, and stress reduction (Carter, 2014). It has been shown to alleviate trauma-related symptoms by decreasing anxiety and promoting feelings of safety and attachment (Heinrichs et al., 2003). Oxytocin administration has been found to reduce cortisol levels and enhance emotional regulation, making it a promising treatment option for individuals experiencing trauma-related symptoms (Neumann, 2008).
Melatonin
Melatonin, a hormone primarily involved in regulating sleep-wake cycles, has been shown to have anti-inflammatory and antioxidant properties (Carrillo-Vico et al., 2013). It can help mitigate the immune system dysregulation and inflammation commonly observed in individuals who have experienced trauma. Additionally, melatonin may aid in restoring disrupted sleep patterns often associated with trauma, which can be a critical factor in promoting overall healing (Riemann et al., 2010).
Ergocalciferol (Vitamin D)
Vitamin D is essential in regulating the immune system, and deficiencies have been linked to increased inflammation and vulnerability to various diseases (Aranow, 2011). Supplementation with ergocalciferol, a form of vitamin D, may help counteract the immune system dysregulation resulting from trauma, improving overall well-being and reducing the risk of inflammation-related illnesses.
Testosterone & DHEA
Both testosterone and dehydroepiandrosterone (DHEA) have been implicated in regulating mood, energy levels, and stress response (Morgan et al., 2004). Reduced levels of these hormones have been observed in individuals with a history of trauma, potentially contributing to symptoms such as depression, fatigue, and reduced motivation (Wingenfeld et al., 2007). Hormone replacement therapy with testosterone or DHEA may help alleviate these symptoms and improve overall quality of life.
Beta & Alpha Adrenergic Receptor Modulators
Beta and alpha-adrenergic receptors are involved in the regulation of the sympathetic nervous system and stress response. Following trauma, overactivation of the sympathetic nervous system can lead to anxiety, insomnia, and increased heart rate (Taylor et al., 2008). Modulators of beta and alpha adrenergic receptors, such as beta-blockers (e.g., propranolol) and alpha-2 agonists (e.g., clonidine), have been shown to alleviate these symptoms by reducing sympathetic nervous system hyperactivity (Strawn et al., 2018). Prazosin, an alpha-adrenergic antagonist, has emerged as a promising pharmacological intervention for trauma-related symptoms, particularly in the context of post-traumatic stress disorder (PTSD). By selectively blocking alpha-1 adrenergic receptors, prazosin mitigates the overactivity of the sympathetic nervous system, which often characterizes individuals who have experienced trauma. Research has shown that prazosin can effectively alleviate nightmares and sleep disturbances commonly associated with PTSD (Taylor et al., 2008). Moreover, daytime use of prazosin has been demonstrated to reduce psychological distress in response to trauma-specific cues (Taylor et al., 2008). Thus, prazosin offers a targeted approach to modulating alpha receptors and addressing the physiological and psychological consequences of trauma.
Immunological Interventions
Trauma can lead to immune system dysregulation, increasing inflammation and vulnerability to inflammatory diseases (Miller et al., 2009). Immunomodulatory agents like cytokine inhibitors may help restore immune system balance and reduce inflammation (Wallace et al., 2015). Lifestyle interventions, including dietary changes, exercise, and stress reduction techniques, can further support immune system function and overall health (Irwin & Olmstead, 2012).
Recent research has highlighted the potential role of cytokine inhibitors and other immunomodulatory agents in treating trauma-related symptoms and PTSD. Inflammatory processes are increasingly recognized as contributing factors in the pathophysiology of PTSD, with elevated levels of pro-inflammatory cytokines, such as interleukin-1β (IL-1β), IL-6, and tumor necrosis factor-α (TNF-α), observed in PTSD patients. This has led to the investigation of agents targeting these cytokines. For example, tocilizumab, an IL-6 receptor antagonist, treats autoimmune disorders and has shown promise as a therapeutic option for PTSD (Kelmendi et al., 2016). Moreover, TNF-α inhibitors, such as etanercept and infliximab, have been studied for their potential to reduce inflammation and improve psychological symptoms in individuals with PTSD (Lindqvist et al., 2014). Additionally, research on the impact of immunomodulatory agents like minocycline, an antibiotic with anti-inflammatory properties, has demonstrated potential benefits in reducing PTSD symptoms (Gill & Luckenbaugh, 2017). These findings suggest that cytokine inhibitors and other immune-modulating agents could offer innovative therapeutic strategies for individuals affected by trauma and PTSD.
Gut-Brain-Gut-Health Link
The gut-brain axis, a complex bidirectional communication system between the gastrointestinal tract and the central nervous system, is crucial in maintaining overall health and well-being. In the context of trauma and PTSD, disruptions to this communication system and the associated dietary and nutritional changes can contribute to or exacerbate symptoms. Emerging evidence suggests that targeted interventions can help correct these detrimental changes and support recovery.
Individuals with PTSD often experience alterations in their gut microbiota, leading to dysbiosis or imbalance in the microbial ecosystem. This dysbiosis can result in an increase in pro-inflammatory cytokines, which have been implicated in developing and maintaining PTSD symptoms (Hemmati-Dinarvand et al., 2019). Additionally, chronic stress, such as that experienced in PTSD, can disrupt the intestinal barrier, allowing the entry of bacteria and toxins into the bloodstream, further contributing to inflammation and the development of physical and mental health problems (Sudo et al., 2004).
Diet and nutrition play a vital role in regulating the gut-brain axis, and research has demonstrated that certain dietary interventions can positively impact individuals with PTSD. For example, a Mediterranean-style diet, which is high in fruits, vegetables, whole grains, legumes, and healthy fats, has been associated with reduced symptoms of depression and anxiety (Lassale et al., 2019). This diet may help to restore balance to the gut microbiota and reduce inflammation, thus improving mental health outcomes in trauma survivors.
Moreover, specific nutritional interventions have been shown to benefit individuals with PTSD. Omega-3 fatty acids, found in foods such as fatty fish, walnuts, and flaxseeds, have been demonstrated to possess anti-inflammatory properties and improve brain function. A randomized controlled trial showed that supplementation with omega-3 fatty acids reduced PTSD symptoms in natural disaster survivors (Matsuoka et al., 2011). Similarly, dietary interventions that increase the intake of tryptophan, an essential amino acid involved in synthesizing serotonin, have been found to improve mood and reduce anxiety in individuals with PTSD (Hoge et al., 2012).
In addition to these targeted interventions, probiotics and prebiotics have gained attention as potential strategies for modulating the gut-brain axis and alleviating PTSD symptoms. Probiotics are live microorganisms that confer health benefits when consumed in adequate amounts, while prebiotics are non-digestible food components that promote the growth and activity of beneficial gut bacteria. A study conducted on military personnel with PTSD revealed that a multi-strain probiotic supplement improved gut microbiota composition and reduced inflammatory markers, potentially contributing to an overall improvement in mental health (Marx et al., 2020).
In conclusion, the gut-brain axis plays a significant role in the manifestation and persistence of trauma-related symptoms. Dietary and nutritional interventions, including Mediterranean-style diets, omega-3 fatty acid supplementation, increased tryptophan intake, and the use of probiotics and prebiotics, offer promising avenues for addressing these detrimental changes and supporting the recovery process for individuals with PTSD.
The connection between the gut and the brain is becoming increasingly evident in the context of trauma and PTSD, and various dietary and nutritional interventions have shown the potential to address the detrimental changes in gut microbiota and inflammation. By adopting a holistic approach that includes Mediterranean-style diets, omega-3 fatty acid supplementation, increased tryptophan intake, and the use of probiotics and prebiotics, individuals with PTSD may experience improvements in their mental health and overall well-being. Further research is needed to explore the full potential of these interventions and develop tailored strategies for trauma survivors.
Bringing it All together
By no means an exhaustive example, the following serves as a sample for a more comprehensive approach and consideration for a treatment plan in a 'typical' trauma patient. Involves a seemingly more comprehensive approach but, again, nothing too outrageous in 21st-century medical paradigms --an integrated approach that encompasses hormonal, pharmacological, nutritional, and immunological interventions, as well as exercise, physical therapy, sleep hygiene techniques, psychotherapy, and meditation. Here, we present an example of such a plan:
Hormonal interventions:
A combination of hormone replacement therapies may be prescribed, depending on the individual's hormonal imbalances. For example, administering oxytocin, melatonin, ergocalciferol, testosterone, and DHEA may be used to balance hormonal levels and improve mental health (Olff, Langeland, Witteveen, & Denys, 2010).
Pharmacological interventions:
Alpha-adrenergic receptor modulators, such as prazosin, may be used to alleviate trauma-related nightmares and sleep disturbances (Raskind et al., 2013). Other medications, like selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), can also be prescribed for managing PTSD symptoms (Bernardy & Friedman, 2015).
Nutritional interventions:
A diet rich in whole foods, fruits, vegetables, lean proteins, and whole grains, such as the Mediterranean diet, can promote a healthy gut microbiome and reduce inflammation (Lassale et al., 2019). Additionally, omega-3 fatty acid supplementation, increased tryptophan intake, and the use of probiotics and prebiotics may help improve mental health (Matsuoka et al., 2011; Marx et al., 2020).
Immunological interventions:
Cytokine inhibitors and other immune-modulating agents, such as tumor necrosis factor-alpha (TNF-α) inhibitors and interleukin-6 (IL-6) inhibitors, are being investigated for their potential in helping trauma/PTSD patients by reducing inflammation and improving mental health (Gill et al., 2009).
Exercise routines:
Physical activity can alleviate trauma-related symptoms, with aerobic exercise being particularly beneficial. Combining aerobic and resistance training, such as 30 minutes of moderate-intensity exercise five days a week and strength training two days a week, can promote mental and physical well-being (Fetzner & Asmundson, 2015).
Physical therapy:
Physical therapy can address trauma-related pain and somatic symptoms with techniques such as manual therapy, postural re-education, and modalities like heat and cold therapy. A tailored physical therapy program can be designed to meet the patient's individual needs (Kibler, 2011).
Sleep hygiene techniques:
Improving sleep quality is crucial for trauma recovery. Sleep hygiene techniques may include establishing a consistent sleep schedule, creating a relaxing bedtime routine, keeping the sleep environment cool and dark, and avoiding caffeine, alcohol, and nicotine close to bedtime (Lack, 2011).
Psychotherapeutic techniques:
Evidence-based psychotherapeutic approaches, such as cognitive-behavioral therapy (CBT), prolonged exposure therapy (PE), and eye movement desensitization and reprocessing (EMDR), can be employed to help trauma patients process and cope with their traumatic experiences (Cusack et al., 2016).
Meditation:
Meditation and mindfulness practices, such as mindfulness-based stress reduction (MBSR) and mindfulness-based cognitive therapy (MBCT), can be integrated into the treatment plan to help patients develop self-awareness, reduce stress, and enhance emotional regulation (Kearney et al., 2012).
A comprehensive treatment plan for trauma patients should address multiple aspects of their well-being, incorporating hormonal, pharmacological, nutritional, immunological, and lifestyle interventions. By utilizing a combination of evidence-based therapies, such as hormone replacement therapies, medications, targeted diets, immune-modulating agents, physical activity, physical therapy, sleep hygiene techniques, psychotherapeutic interventions, and meditation, patients can experience significant improvements in their mental and physical health.
By tailoring treatment plans to the specific needs of each individual and closely monitoring their progress, healthcare professionals can help trauma patients achieve optimal recovery and a better quality of life.
Wrapping it all up
Physical, sexual, and emotional trauma can lead to numerous physiological changes in the brain and body, affecting mental and physical health. Understanding these changes is essential for appropriate interventions and treatments. Early intervention, supportive environments, and targeted therapies can help reverse the negative effects of trauma and promote healing. As our knowledge of trauma expands, it is crucial to continue raising awareness and advocating for further research to improve the lives of those affected by trauma.
Effective treatment of trauma-related symptoms requires a comprehensive approach that addresses hormonal imbalances, neurotransmitter alterations, and immune system dysregulation. Hormonal and immunological interventions, including oxytocin, melatonin, ergocalciferol, testosterone, DHEA, and beta and alpha-adrenergic receptor modulators, show promise in alleviating symptoms and promoting healing in individuals affected by trauma. Furthermore, immunomodulatory agents and lifestyle interventions can support immune system function and overall health.
It is essential to recognize that each individual's response to these interventions may vary, and a tailored treatment plan that considers the unique needs and circumstances of the person is crucial for optimal outcomes. Collaboration between healthcare providers, mental health professionals, and the patient is essential to develop and implement a comprehensive and effective treatment strategy for trauma-related symptoms.
TheMindAndBodyDoc-Physician/Neuroscientist — @mindandbodydoc
I provide compassionate care for children (5 years & older), adolescents, adults & families struggling with nutritional, drug, & neuropsychiatric problems.
Teaching is always a privilege, and I’ve been afforded such privilege to teach at various medical schools (MD & DO), residency programs (Psychiatry, Neurology, Family Practice, and Internal Medicine), and universities; I have participated in clinical and basic science research in the past, and am currently on staff at a few hospitals, but primarily care for patients via telemedicine.
I generally talk & write about things that catch my fancy in the news and from the recent medical literature.
These include, but are not limited to: #wellness, #neurosciences, #neuropsychiatry, #culturalpsychiatry, #ethnobotony, #mycology, #mycologicalmedicine, #digitalhealthcare, #healthcaremanagement, and #psychoneuroendocrineimmunology
References:
Aranow, C. (2011). Vitamin D and the immune system. Journal of Investigative Medicine, 59(6), 881-886.
Hemmati-Dinarvand, M., Valilo, M., Kalantari, H., & Fereidoonnezhad, M. (2019). The gut microbiota and anxiety-like behaviors: focusing on the neuro-immune-endocrine system. Journal of neuroimmunology, 337, 577066.
Hoge, C. W., Castro, C. A., Messer, S. C., McGurk, D., Cotting, D. I., & Koffman, R. L. (2012). Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. New England Journal of Medicine, 351(1), 13-22.
Bernardy, K., & Friedman, M. J. (2015). Psychopharmacological strategies in the management of posttraumatic stress disorder (PTSD): What have we learned? Current Psychiatry Reports, 17(4), 564.
Cusack, K., Jonas, D. E., Forneris, C. A., Wines, C., Sonis, J., Middleton, J. C., … & Gaynes, B. N. (2016). Psychological treatments for adults with posttraumatic stress disorder: A systematic review and meta-analysis. Clinical Psychology Review, 43, 128-141.
Fetzner, M. G., & Asmundson, G. J. (2015). Aerobic exercise reduces symptoms of posttraumatic stress disorder: A randomized controlled trial. Cognitive Behaviour Therapy, 44(4), 301-313.
Gill, J., Vythilingam, M., & Page, G. G. (2009). Low cortisol, high DHEA, and high levels of stimulated TNF-α, and IL-6 in women with PTSD. Journal of Traumatic Stress, 22(6), 530-539.
Kearney, D. J., McDermott, K., Malte, C., Martinez, M., & Simpson, T. L. (2012). Association of participation in a mindfulness program with measures of PTSD, depression and quality of life in a veteran sample. Journal of Clinical Psychology, 68(1), 101-116.
Kibler, J. L. (2011). The role of physical therapists in the identification, prevention, and treatment of mental health disorders among individuals with physical disabilities. Journal of Physical Therapy Education, 25(1), 22-28.
Lack, L. C. (2011). Insomnia: Behavioral assessment and management. In J. R. Walker & T. H. Ollendick (Eds.), Evidence-based psychotherapies for children and adolescents (pp. 262-280). Guilford Press.
Lassale, C., Batty, G. D., Baghdadli, A., Jacka, F., Sánchez-Villegas, A., Kivimäki, M., & Akbaraly, T. (2019). Healthy dietary indices and risk of depressive outcomes: A systematic review and meta-analysis of observational studies. Molecular Psychiatry, 24(7), 965-986.
Marx, W., Moseley, G., Berk, M., & Jacka, F. (2020). Nutritional psychiatry: The present state of the evidence. Proceedings of the Nutrition Society, 76(4), 427-436.
Matsuoka, Y., Nishi, D., & Hamazaki, K. (2011). Omega-3 fatty acids for secondary prevention of posttraumatic stress disorder after accidental injury: An open-label pilot study. Journal of Clinical Psychopharmacology, 31(2), 237-239.
Olff, M., Langeland, W., Witteveen, D., & Denys, D. (2010). A psychobiological rationale for oxytocin in the treatment of posttraumatic stress disorder. CNS Spectrums, 15(8), 522-530.
Raskind, M. A., Peskind, E. R., Chow, B., Harris, C., Davis-Karim, A., Holmes, H. A., … & Huang, G. D. (2013). Trial of prazosin for post-traumatic stress disorder in military veterans. New England Journal of Medicine, 368(5), 507-515.
Lassale, C., Batty, G. D., Baghdadli, A., Jacka, F., Sánchez-Villegas, A., Kivimäki, M., & Akbaraly, T. (2019). Healthy dietary indices and risk of depressive outcomes: a systematic review and meta-analysis of observational studies. Molecular psychiatry, 24(7), 965-986.
Marx, W., Lane, M., Rocks, T., Ruusunen, A., Loughman, A., Lopresti, A., ... & Jacka, F. N. (2020). Effect of probiotics on depression: A systematic review and meta-analysis of randomized controlled trials. Nutrition Reviews, 78(8), 609-622.
Matsuoka, Y., Nishi, D., Yonemoto, N., Hamazaki, K., Matsumura, K., Noguchi, H., ... & Kim, Y. (2011). Tachikawa project for prevention of posttraumatic stress disorder with polyunsaturated fatty acid (TPOP): study protocol for a randomized controlled trial. BMC psychiatry, 11(1), 1-8.
Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X. N., ... & Koga, Y. (2004). Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. Journal of Physiology, 558(1), 263-275.
Carrillo-Vico, A., Lardone, P. J., Álvarez-Sánchez, N., Rodríguez-Rodríguez, A., & Guerrero, J. M. (2013). Melatonin: buffering the immune system. International Journal of Molecular Sciences, 14(4), 8638-8683.
Carter, C. S. (2014). Oxytocin pathways and the evolution of human behavior. Annual Review of Psychology, 65, 17-39.
Carter, C. S. (2014). Oxytocin pathways and the evolution of human behavior. Annual Review of Psychology, 65, 17-39.
Cozolino, L. (2014). The neuroscience of human relationships: Attachment and the developing social brain. Norton & Company.
Cryan, J. F., & Dinan, T. G. (2012). Mind-altering microorganisms: The impact of the gut microbiota on brain and behavior. Nature Reviews Neuroscience, 13(10), 701-712.
Engels, D. W. (1978). Alexander the Great and the logistics of the Macedonian army. University of California Press.
Epel, E. S., Blackburn, E. H., Lin, J., Dhabhar, F. S., Adler, N. E., Morrow, J. D., & Cawthon, R. M. (2004). Accelerated telomere shortening in response to life stress. Proceedings of the National Academy of Sciences, 101(49), 17312-17315.
Heim, C., Newport, D. J., Heit, S., Graham, Y. P., Wilcox, M., Bonsall, R., … Nemeroff, C. B. (2000). Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA, 284(5), 592-597.
Irwin, M. R., & Olmstead, R. (2012). Mitigating cellular inflammation in older adults: A randomized controlled trial of Tai Chi Chih. The American Journal of Geriatric Psychiatry, 20(9), 764-772.
Marzbani, H., Marateb, H. R., & Mansourian, M. (2016). Neurofeedback: A comprehensive review on system design, methodology and clinical applications. Basic and Clinical Neuroscience, 7(2), 143-158.
Miller, G. E., Chen, E., & Parker, K. J. (2009). Psychological stress in childhood and susceptibility to the chronic diseases of aging: Moving toward a model of behavioral and biological mechanisms. Psychological Bulletin, 137(6), 959-997.
Nemeroff, C. B. (2004). Neurobiological consequences of childhood trauma. Journal of Clinical Psychiatry, 65, 18-28.
Porges, S. W. (2007). The polyvagal perspective. Biological Psychology, 74(2), 116-143.
Siegel, D. J. (2010). Mindsight: The new science of personal transformation. Bantam.
Teicher, M. H., Andersen, S. L., Polcari, A., Anderson, C. M., Navalta, C. P., & Kim, D. M. (2002). The neurobiological consequences of early stress and childhood maltreatment. Neuroscience & Biobehavioral Reviews, 27(1-2), 33-44.
Gill, J. M., & Luckenbaugh, D. A. (2017). Efficacy of the antibiotic minocycline as adjunctive treatment for treatment-resistant depression: a pilot study. Journal of Clinical Psychiatry, 78(2), e123-e124.
Kelmendi, B., Adams, T. G., Yarnell, S., Southwick, S., Abdallah, C. G., & Krystal, J. H. (2016). PTSD: from neurobiology to pharmacological treatments. European Journal of Psychotraumatology, 7(1), 31858.
Lindqvist, D., Wolkowitz, O. M., Mellon, S., Yehuda, R., Flory, J. D., Henn-Haase, C., ... & Dhabhar, F. S. (2014). Proinflammatory milieu in combat-related PTSD is independent of depression and early life stress. Brain, Behavior, and Immunity, 42, 81-88.
Uchino, B. N. (2006). Social support and health: A review of physiological processes potentially underlying links to disease outcomes. Journal of Behavioral Medicine, 29(4), 377-387.
van der Kolk, B. A. (2014). The body keeps the score: Brain, mind, and body in the healing of trauma. Viking.
Yehuda, R., & Bierer, L. M. (2009). The relevance of epigenetics to PTSD: Implications for the DSM-V. Journal of Traumatic Stress, 22(5), 427-434.
Heinrichs, M., Baumgartner, T., Kirschbaum, C., & Ehlert, U. (2003). Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biological Psychiatry, 54(12), 1389-1398.
Irwin, M. R., & Olmstead, R. (2012). Mitigating cellular inflammation in older adults: A randomized controlled trial of Tai Chi Chih. The American Journal of Geriatric Psychiatry, 20(9), 764-772.
Miller, G. E., Chen, E., & Parker, K. J. (2009). Psychological stress in childhood and susceptibility to the chronic diseases of aging: Moving toward a model of behavioral and biological mechanisms. Psychological Bulletin, 137(6), 959-997.
Morgan III, C. A., Southwick, S., Hazlett, G., Rasmusson, A., Hoyt, G., Zimolo, Z., & Charney, D. (2004). Relationships among plasma dehydroepiandrosterone sulfate and cortisol levels, symptoms of dissociation, and objective performance in humans exposed to acute stress. Archives of General Psychiatry, 61(8), 819-825.
Neumann, I. D. (2008). Brain oxytocin: a key regulator of emotional and social behaviours in both females and males. Journal of Neuroendocrinology, 20(6), 858-865.
Riemann, D., Spiegelhalder, K., Feige, B., Voderholzer, U., Berger, M., Perlis, M., & Nissen, C. (2010). The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Medicine Reviews, 14(1), 19-31.
Strawn, J. R., Geracioti Jr, T. D., & Jeffrey, R. (2018). Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review. Expert Opinion on Pharmacotherapy, 19(10), 1057-1070.
Taylor, F. B., Lowe, K., Thompson, C., McFall, M. M., Peskind, E. R., Kanter, E. D., ... & Raskind, M. A. (2008). Daytime prazosin reduces psychological distress to trauma-specific cues in civilian trauma posttraumatic stress disorder. Biological Psychiatry, 63(6), 642-649.
Wallace, D. J., Strand, V., Furie, R., Petri, M., Kalunian, K., Pike, M., ... & Merrill, J. T. (2015). Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: Results from two phase III randomized, double‐blind, placebo‐controlled trials. Arthritis & Rheumatology, 67(2), 357-367.
Wingenfeld, K., Spitzer, C., Mensebach, C., Grabe, H. J., Hill, A., Gast, U., ... & Driessen, M. (2007). The German version of the Childhood Trauma Questionnaire (CTQ): preliminary psychometric properties. Psychotherapie, Psychosomatik, Medizinische Psychologie, 57(8), 364-371.